Mr. Steve West reports

MARIMED ANNOUNCES MANAGEMENT CHANGE AND THIRD QUARTER 2023 EARNINGS DATE

Marimed Inc.'s Susan M. Villare resigned as chief financial officer of the company, effective Oct. 31, 2023. The board of directors has appointed Jon Levine, president and chief executive officer, as the company's interim chief financial officer, and has initiated a search process to identify and engage a new chief financial officer.

Additionally, the company announced it will report third quarter 2023 financial results on Nov. 8, 2023, after the markets close. Management will host a conference call on Nov. 9, 2023, at 8 a.m. ET to discuss financial results.

A webcast will be available and can be accessed via Marimed's investor relations website. A playback of the call will also be made available on Marimed's investor relations website.

About Marimed Inc.

Marimed, a multistate cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions and its values. The company develops, owns and manages seed-to-sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products and dispensary operations. Marimed has an experienced management team that has produced consistent growth and success for the company and its managed business units. Proprietary formulations created by the company's technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature's Heritage, InHouse, Bubby's Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy.